Compare CSTE & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSTE | LNSR |
|---|---|---|
| Founded | 1987 | 2004 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Building Materials | Medical Electronics |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.4M | 69.1M |
| IPO Year | 2012 | 2005 |
| Metric | CSTE | LNSR |
|---|---|---|
| Price | $2.12 | $5.62 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 187.7K | 90.2K |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $58,435,000.00 |
| Revenue This Year | $3.43 | $10.06 |
| Revenue Next Year | $2.83 | $41.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 9.24 |
| 52 Week Low | $0.56 | $5.06 |
| 52 Week High | $2.62 | $13.32 |
| Indicator | CSTE | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 47.15 | 45.01 |
| Support Level | $2.12 | $5.58 |
| Resistance Level | $2.59 | $6.20 |
| Average True Range (ATR) | 0.15 | 0.21 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 10.06 | 27.91 |
Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa), of which it derives maximum revenue from United States.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.